According to a pooled data analysis of the available evidence from clinical trials, which was published online in the British Journal of Sports Medicine, static isometric exercises—the kind that involves engaging muscles without movement, such as wall sits and planks—are the best for lowerin
In a randomised clinical trial reported at Nutrition 2023, the annual conference of the American Society of Nutrition (ASN), daily strawberry consumption was connected to improved cognitive performance, reduced blood pressure, and higher antioxidant capacity. The study, performed at San Die
Anaheim (California) [US], July 25: Fapon, a global leading life sciences company, has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global markets at the 2023 AACC exhibition. The high-speed and fully automated analyzer has an ultra-high through
The finding, which was reported in the Proceedings of the National Academy of Sciences journal, completely rewrites our understanding of the immune cell landscape in a healthy human eye's cornea.
Anaheim (California) [US], July 25: Fapon, a leading life science company, will showcase its latest innovations in in-vitro diagnostic and biopharma solutions at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo from July 25 to 27.
Bengaluru (Karnataka) [India], July 24: Nesa Medtech (Nesa), a private medical device company addressing clinical unmet needs for patients with symptomatic uterine fibroids, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company's F
Chennai (Tamil Nadu) [India], July 24: Acentra Health welcomed U.S. Consul General in Chennai Judith Ravin at a celebration in Chennai on Friday, July 21, 2023, to inaugurate the U.S.-based company’s new brand and its continued investment in its growing India-based technology development wor
Radiation therapy for patients with prostate cancer can be made safer by a method that uses imaging technology as a guide. This method enables doctors to precisely direct radiation beams towards the prostate while avoiding adjacent tissue in the bladder, urethra, and rectum.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.